J.C. Stoof
About
J.C. Stoof is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Neurology.
According to data from OpenAlex, J.C. Stoof has authored 68 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Cellular and Molecular Neuroscience, 24 papers in Molecular Biology and 24 papers in Neurology. Recurrent topics in J.C. Stoof's work include Neuroscience and Neuropharmacology Research (22 papers), Neurotransmitter Receptor Influence on Behavior (20 papers) and Neurological disorders and treatments (20 papers). J.C. Stoof is often cited by papers focused on Neuroscience and Neuropharmacology Research (22 papers), Neurotransmitter Receptor Influence on Behavior (20 papers) and Neurological disorders and treatments (20 papers). J.C. Stoof collaborates with scholars based in Netherlands, United States and Belgium. J.C. Stoof's co-authors include John W. Kebabian, Benjamin Drukarch, Gerrit Tissingh, Jan Booij, Erik Ch. Wolters, Eric A. van Royen, J.E. Leysen, Paul Bergmans, A.G.M. Janssen and Ania Winogrodzka and has published in prestigious journals such as Nature, Journal of Neuroscience and The Journal of Physiology.
In The Last Decade
J.C. Stoof
67 papers receiving 4.9k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| J.C. Stoof Netherlands | 37 | 3.2k | 2.1k | 1.3k | 439 | 375 | 68 | 5.0k | ||
| Mario Herrera‐Marschitz Sweden | 47 | 4.5k 1.4× | 2.6k 1.2× | 1.2k 0.9× | 289 0.7× | 874 2.3× | 209 | 7.2k | ||
| I J Kopin United States | 34 | 2.1k 0.7× | 1.1k 0.5× | 793 0.6× | 216 0.5× | 667 1.8× | 70 | 4.2k | ||
| Andrew B. Norman United States | 34 | 2.2k 0.7× | 1.6k 0.7× | 523 0.4× | 192 0.4× | 227 0.6× | 135 | 3.5k | ||
| Vincent Leviel France | 33 | 2.3k 0.7× | 1.2k 0.6× | 580 0.4× | 204 0.5× | 282 0.8× | 78 | 3.4k | ||
| Roser Cortés Spain | 43 | 4.2k 1.3× | 2.6k 1.3× | 575 0.4× | 418 1.0× | 717 1.9× | 92 | 5.8k | ||
| A. Chéramy France | 47 | 5.3k 1.7× | 2.6k 1.3× | 1.1k 0.8× | 310 0.7× | 831 2.2× | 98 | 6.3k | ||
| C Pycock United Kingdom | 31 | 2.7k 0.8× | 1.1k 0.5× | 721 0.5× | 522 1.2× | 382 1.0× | 84 | 3.8k | ||
| Henry Sershen United States | 43 | 3.4k 1.1× | 2.9k 1.4× | 460 0.3× | 366 0.8× | 672 1.8× | 164 | 5.4k | ||
| G. Toffano Italy | 40 | 3.4k 1.1× | 2.9k 1.4× | 651 0.5× | 224 0.5× | 863 2.3× | 170 | 6.0k | ||
| Marie‐Jo Besson France | 38 | 3.9k 1.2× | 2.4k 1.2× | 715 0.5× | 195 0.4× | 489 1.3× | 86 | 5.1k |
Countries citing papers authored by J.C. Stoof
Since
Specialization
Citations
This map shows the geographic impact of J.C. Stoof's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.C. Stoof with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.C. Stoof more than expected).
Fields of papers citing papers by J.C. Stoof
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by J.C. Stoof. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.C. Stoof. The network helps show where J.C. Stoof may publish in the future.
Co-authorship network of co-authors of J.C. Stoof
This figure shows the co-authorship network connecting the top 25 collaborators of J.C. Stoof. A scholar is included among the top collaborators of J.C. Stoof based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.C. Stoof. J.C. Stoof is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Tissingh, Gerrit, Henk W. Berendse, Paul Bergmans, et al.. (2001). Loss of olfaction in de novo and treated Parkinson's disease: Possible implications for early diagnosis. Movement Disorders. 16(1). 41–46.
2.
Andringa, Gerda, J.C. Stoof, & A.R. Cools. (1999). Sub-chronic administration of the dopamine D 1 antagonist SKF 83959 in bilaterally MPTP-treated rhesus monkeys: stable therapeutic effects and wearing-off dyskinesia. Psychopharmacology. 146(3). 328–334.
3.
Andringa, Gerda, et al.. (1999). The validity of the pretreated, unilaterally MPTP-treated monkey as a model of Parkinson's disease. Behavioural Pharmacology. 10(2). 163–173.
4.
Tissingh, Gerrit, Paul Bergmans, Jan Booij, et al.. (1997). [123I]β-CIT single-photon emission tomography in Parkinson's disease reveals a smaller decline in dopamine transporters with age than in controls. European Journal of Nuclear Medicine and Molecular Imaging. 24(9). 1171–1174.
5.
Drukarch, Benjamin, Erik Schepens, Cornelis A.M. Jongenelen, J.C. Stoof, & Cornelis H. Langeveld. (1997). Astrocyte-mediated enhancement of neuronal survival is abolished by glutathione deficiency. Brain Research. 770(1-2). 123–130.
6.
Muiswinkel, F. L. Van, John G. J. M. Bol, Jan M. Ruijter, et al.. (1995). Repeated administration of a selective dopamine D2 receptor agonist to 6-OHDA — lesioned rats does not affect the survival and outgrowth of intrastriatal fetal mesencephalic grafts. Experimental Brain Research. 107(1). 52–58.
7.
Vermeulen, R. Jeroen, E.Ch. Wolters, Gerrit Tissingh, et al.. (1995). Evaluation of [123I]β-CIT binding with SPECT in controls, early and late Parkinson's disease. Nuclear Medicine and Biology. 22(8). 985–991.
8.
Vermeulen, R. Jeroen, Benjamin Drukarch, Erik Ch. Wolters, et al.. (1995). Morphine and naltrexone modulate D2 but not D1 receptor induced motor behavior in MPTP-lesioned monkeys. Psychopharmacology. 118(4). 451–459.
9.
Henselmans, J.M.L., et al.. (1993). Regional differences in the dopaminergic regulation of cyclic AMP formation within the rat nucleus accumbens: comparison with the striatal complex of the lizard Gekko gecko. Neuroscience Letters. 158(1). 79–82.
10.
Muiswinkel, F. L. Van, Benjamin Drukarch, H.W.M. Steinbusch, & J.C. Stoof. (1993). Chronic Dopamine D2 Receptor Activation Does Not Affect Survival and Differentiation of Cultured Dopaminergic Neurons: Morphological and Neurochemical Observations. Journal of Neurochemistry. 60(1). 83–92.
11.
Stoof, J.C., et al.. (1992). In vitro and in vivo acetylcholine release from rat striatum as a functional paradigm of signal transduction via a D-2 dopamine receptor. Neurochemistry International. 20. 201–205.
12.
Langeveld, Cornelis H., et al.. (1992). Implication of glucocorticoid receptors in the stimulation of human glioma cell proliferation by dexamethasone. Journal of Neuroscience Research. 31(3). 524–531.
13.
Stoof, J.C., et al.. (1992). Dopamine D2 receptor stimulation differentially affects voltage‐activated calcium channels in rat pituitary melanotropic cells.. The Journal of Physiology. 450(1). 409–435.
14.
Boer, Peter de, et al.. (1992). The effect of intrastriatal application of directly and indirectly acting dopamine agonists and antagonists on the in vivo release of acetylcholine measured by brain microdialysis. Naunyn-Schmiedeberg s Archives of Pharmacology. 345(2). 144–152.
15.
Henselmans, J.M.L., Piet V. Hoogland, & J.C. Stoof. (1991). Differences in the regulation of acetylcholine release upon D2 dopamine and N-methyl-d-aspartate receptor activation between the striatal complex of reptiles and the neostriatum of rats. Brain Research. 566(1-2). 8–12.
16.
Henselmans, J.M.L. & J.C. Stoof. (1991). Regional differences in the regulation of acetylcholine release upon D2 dopamine and N-methyl-d-aspartate receptor activation in rat nucleus accumbens and neostriatum. Brain Research. 566(1-2). 1–7.
17.
Drukarch, Benjamin & J.C. Stoof. (1990). D-2 dopamine autoreceptor selective drugs: Do they really exist?. Life Sciences. 47(5). 361–376.
18.
Drukarch, Benjamin, Erik Schepens, & J.C. Stoof. (1990). Muscarinic receptor activation attenuates D2 dopamine receptor mediated inhibition of acetylcholine release in rat striatum: Indications for a common signal transduction pathway. Neuroscience. 37(1). 1–9.
19.
Bruyn, R.P.M. & J.C. Stoof. (1990). The quinolinic acid hypothesis in Huntington's chorea. Journal of the Neurological Sciences. 95(1). 29–38.
20.
Drukarch, Benjamin, Erik Schepens, Anton N. M. Schoffelmeer, & J.C. Stoof. (1989). Stimulation of D‐2 Dopamine Receptors Decreases the Evoked In Vitro Release of [3H] Acetylcholine from Rat Neostriatum: Role of K+ and Ca2+. Journal of Neurochemistry. 52(6). 1680–1685.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Mario Herrera‐Marschitz Breakdown of academic impact, for papers by I J Kopin Breakdown of academic impact, for papers by Andrew B. Norman Breakdown of academic impact, for papers by Vincent Leviel Breakdown of academic impact, for papers by Roser Cortés Breakdown of academic impact, for papers by A. Chéramy Breakdown of academic impact, for papers by C Pycock Breakdown of academic impact, for papers by Henry Sershen Breakdown of academic impact, for papers by G. Toffano Breakdown of academic impact, for papers by Marie‐Jo Besson